advertisement

WGA Rescources

11.8 Neuroprotection (17)

Showing records 1 to 17

Display all abstracts in classification 11.8 Neuroprotection

Search within classification 11.8 Neuroprotection
50263 Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy
Nickells RW; Howell GR; Soto I; John SW
Annual review of neuroscience 2012; 35: 153-179
50614 Stem cell-based delivery of brain-derived neurotrophic factor gene in the rat retina
Park HY; Kim JH; Sun Kim H; Park CK
Brain Research 2012; 1469: 10-23
50358 Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma
Wiggs JL; Yaspan BL; Hauser MA; Kang JH; Allingham RR; Olson LM; Abdrabou W; Fan BJ; Wang DY; Brodeur W; Budenz DL; Caprioli J; Crenshaw A; Crooks K; Delbono E; Doheny KF; Friedman DS; Gaasterland D; Gaasterland T; Laurie C; Lee RK; Lichter PR; Loomis S
PLoS Genetics 2012; 8: e1002654
50595 YC-1 targeting of hypoxia-inducible factor-1α reduces RGC-5 cell viability and inhibits cell proliferation
Tsui L; Fong TH; Wang IJ
Molecular Vision 2012; 18: 1594-1603
50391 Preclinical models to investigate retinal ischemia: advances and drawbacks
Minhas G; Morishita R; Anand A
Frontiers in neurology 2012; 3: 75
50353 An astrocyte-specific proteomic approach to * inflammatory responses in experimental rat glaucoma
Tezel G; Yang X; Luo C; Cai J; Powell DW
Investigative Ophthalmology and Visual Science 2012; 53: 4220-4233
50189 Activation of autophagy induces retinal ganglion cell death in a chronic hypertensive glaucoma model
Park HY; Kim JH; Park CK
Cell Death and Disease 2012; 3: e290
50470 Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model
Husain S; Abdul Y; Crosson CE
Investigative Ophthalmology and Visual Science 2012; 53: 4289-4298
50262 Retinal ganglion cell (RGC) death in glaucomatous beagles is not associated with mutations in p53 and NTF4 genes
Kato K; Sasaki N; Shastry BS
Veterinary Ophthalmology 2012; 15: 8-12
50493 A Potential Neuroprotective Role of Apolipoprotein E-containing Lipoproteins through Low Density Lipoprotein Receptor-related Protein 1 in Normal Tension Glaucoma
Hayashi H; Eguchi Y; Fukuchi-Nakaishi Y; Takeya M; Nakagata N; Tanaka K; Vance JE; Tanihara H
Journal of Biological Chemistry 2012; 287: 25395-25406
50596 Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action
Shih GC; Calkins DJ
Expert Review of Ophthalmology 2012; 7: 161-175
50426 N-Acetylcysteine Protects Against Hypoxia Mimetic-Induced Autophagy by Targeting the HIF-1α Pathway in Retinal Ganglion Cells
Yang L; Tan P; Zhou W; Zhu X; Cui Y; Zhu L; Feng X; Qi H; Zheng J; Gu P; Fan X; Chen H
Cellular and molecular neurobiology 2012; 32: 1275-1285
50424 Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors
de Lima S; Koriyama Y; Kurimoto T; Oliveira JT; Yin Y; Li Y; Gilbert HY; Fagiolini M; Martinez AM; Benowitz L
Proceedings of the National Academy of Sciences of the United States of America 2012; 109: 9149-9154
50649 Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
Agarwal R; Agarwal P
Indian Journal of Ophthalmology 2012; 60: 255-261
50655 Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma
Alqawlaq S; Huzil JT; Ivanova MV; Foldvari M
Nanomedicine 2012; 7: 1067-1083
50406 Effect of Ginkgo biloba Extract on Visual Field Progression in Normal Tension Glaucoma
Lee J; Sohn SW; Kee C
Journal of Glaucoma 2013; 22: 780-784
50608 Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Husain S; Abdul Y; Potter DE
Current Pharmaceutical Design 2012; 18: 6101-6108

Issue 14-2

Change Issue


advertisement

Oculus